Literature DB >> 21325272

Natural loss-of-function mutation of myeloid differentiation protein 88 disrupts its ability to form Myddosomes.

Kamalpreet Nagpal1, Theo S Plantinga, Cherilyn M Sirois, Brian G Monks, Eicke Latz, Mihai G Netea, Douglas T Golenbock.   

Abstract

Myeloid differentiation protein 88 (MyD88) is a key signaling adapter in Toll-like receptor (TLR) signaling. MyD88 is also one of the most polymorphic adapter proteins. We screened the reported nonsynonymous coding mutations in MyD88 to identify variants with altered function. In reporter assays, a death domain variant, S34Y, was found to be inactive. Importantly, in reconstituted macrophage-like cell lines derived from knock-out mice, MyD88 S34Y was severely compromised in its ability to respond to all MyD88-dependent TLR ligands. Unlike wild-type MyD88, S34Y is unable to form distinct foci in the cells but is present diffused in the cytoplasm. We observed that IRAK4 co-localizes with MyD88 in these aggregates, and thus these foci appear to be "Myddosomes." The MyD88 S34Y loss-of-function mutant demonstrates how proper cellular localization of MyD88 to the Myddosome is a feature required for MyD88 function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325272      PMCID: PMC3064238          DOI: 10.1074/jbc.M110.199653

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  MAP kinases in the immune response.

Authors:  Chen Dong; Roger J Davis; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.

Authors:  Annett Schoenemeyer; Betsy J Barnes; Margo E Mancl; Eicke Latz; Nadege Goutagny; Paula M Pitha; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  J Biol Chem       Date:  2005-01-28       Impact factor: 5.157

3.  Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.

Authors:  Frank P Mockenhaupt; Jakob P Cramer; Lutz Hamann; Miriam S Stegemann; Jana Eckert; Na-Ri Oh; Rowland N Otchwemah; Ekkehart Dietz; Stephan Ehrhardt; Nicolas W J Schröder; Ulrich Bienzle; Ralf R Schumann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

4.  Ultrastructural distribution of the death-domain-containing MyD88 protein in HeLa cells.

Authors:  F Jaunin; K Burns; J Tschopp; T E Martin; S Fakan
Journal:  Exp Cell Res       Date:  1998-08-25       Impact factor: 3.905

5.  Versatile retroviral vectors for potential use in gene therapy.

Authors:  R G Hawley; F H Lieu; A Z Fong; T S Hawley
Journal:  Gene Ther       Date:  1994-03       Impact factor: 5.250

6.  Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis.

Authors:  Lutz Hamann; Christiane Glaeser; Axel Hamprecht; Michael Gross; Abuzeid Gomma; Ralf R Schumann
Journal:  Clin Chim Acta       Date:  2005-08-24       Impact factor: 3.786

7.  The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation.

Authors:  T T Yamin; D K Miller
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

Review 8.  The importance of Toll-like receptor 2 polymorphisms in severe infections.

Authors:  Joelle Texereau; Jean-Daniel Chiche; William Taylor; Gerald Choukroun; Beatrice Comba; Jean-Paul Mira
Journal:  Clin Infect Dis       Date:  2005-11-15       Impact factor: 9.079

9.  Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.

Authors:  Julie George; Precious G Motshwene; Hui Wang; Andriy V Kubarenko; Anna Rautanen; Tara C Mills; Adrian V S Hill; Nicholas J Gay; Alexander N R Weber
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

10.  LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.

Authors:  Katherine A Fitzgerald; Daniel C Rowe; Betsy J Barnes; Daniel R Caffrey; Alberto Visintin; Eicke Latz; Brian Monks; Paula M Pitha; Douglas T Golenbock
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

View more
  18 in total

1.  TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages.

Authors:  Christian P Bauerfeld; Ruchi Rastogi; Gaila Pirockinaite; Icksoo Lee; Maik Hüttemann; Bobby Monks; Morris J Birnbaum; Luigi Franchi; Gabriel Nuñez; Lobelia Samavati
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

2.  Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling.

Authors:  Ota Fekonja; Mojca Benčina; Roman Jerala
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

3.  A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival.

Authors:  Hui Wang; Sinead M Flannery; Sabine Dickhöfer; Stefanie Huhn; Julie George; Andriy V Kubarenko; Jesus Lascorz; Melanie Bevier; Joschka Willemsen; Tica Pichulik; Clemens Schafmayer; Marco Binder; Bénédicte Manoury; Søren R Paludan; Marta Alarcon-Riquelme; Andrew G Bowie; Asta Försti; Alexander N R Weber
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

4.  Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signaling.

Authors:  Thomas Ve; Parimala R Vajjhala; Andrew Hedger; Tristan Croll; Frank DiMaio; Shane Horsefield; Xiong Yu; Peter Lavrencic; Zahid Hassan; Garry P Morgan; Ashley Mansell; Mehdi Mobli; Ailis O'Carroll; Brieuc Chauvin; Yann Gambin; Emma Sierecki; Michael J Landsberg; Katryn J Stacey; Edward H Egelman; Bostjan Kobe
Journal:  Nat Struct Mol Biol       Date:  2017-07-31       Impact factor: 15.369

5.  Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility.

Authors:  Yunhao Tan; Jonathan C Kagan
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

Review 6.  Genetic variation in Toll-like receptors and disease susceptibility.

Authors:  Mihai G Netea; Cisca Wijmenga; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2012-05-18       Impact factor: 25.606

7.  Rhinovirus-induced macrophage cytokine expression does not require endocytosis or replication.

Authors:  Thomas G Saba; Yutein Chung; Jun Young Hong; Uma S Sajjan; J Kelley Bentley; Marc B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

Review 8.  Intracellular nucleic acid sensors and autoimmunity.

Authors:  Argyrios N Theofilopoulos; Dwight H Kono; Bruce Beutler; Roberto Baccala
Journal:  J Interferon Cytokine Res       Date:  2011-10-27       Impact factor: 2.607

9.  MyD88 interacts with interferon regulatory factor (IRF) 3 and IRF7 in Atlantic salmon (Salmo salar): transgenic SsMyD88 modulates the IRF-induced type I interferon response and accumulates in aggresomes.

Authors:  Dimitar B Iliev; Mehrdad Sobhkhez; Kjersti Fremmerlid; Jorunn B Jørgensen
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

10.  Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

Authors:  Jin Wang; Anatoly V Grishin; Henri R Ford
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.